Screener/Healthcare/Biotechnology

IOVA

Iovance Biotherapeutics, Inc.NASDAQ
$3.63+0.01 (+0.14%)
$1.64
$5.63
$3.43
$3.68
EPS (TTM)$-1.22
P/E Ratio
Dividend Yield
Market Cap$1.79B
Volume9.73M
Prev Close$3.63
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$67.5M-$91.3M$-0.2543.0%-135.3%
Q2 '25$60.0M-$111.7M$-0.335.5%-186.2%
Q1 '25$49.3M-$116.2M$-0.36-0.8%-235.5%
Q3 '24$58.6M-$83.5M$-0.2832.0%-142.7%
Q2 '24$31.1M-$97.1M$-0.34-0.8%-312.2%
Q1 '24$715K-$113.0M$-0.42-915.5%-15800.8%
Q4 '23$482K-$116.4M$-0.45-805.6%-24145.0%
Q3 '23$469K-$113.8M$-0.46-825.4%-24255.9%
Get Your Daily Market Recap